US$ 26.55
glp 1 agonist brand names india Latin America Glucagon-like Peptide-1 Agonists Market - GLP-1 Glenmark launches biosimilar of anti-diabetic
Description
J Clin Invest 113, 635645 (2004)

Dai Y, Dai D, Wang X, Ding Z, Li C, Mehta JL
Malik, J

In contrast to RCTs, retrospective observational studies offer the benefit of capturing extensive patient data in real-world settings

49 Secondly, its safety and efficacy remain unclear in patients with a history of pancreatitis as it has not been studied in this group

54,55 By doing so, the resulting product has a higher similarity or homology to the amino acid sequence of human GLP-1
